Detailed haplotype analysis in Ashkenazi Jewish and non-Jewish British dystonic patients carrying the GAG deletion in the DYT1 gene: evidence for a limited number of founder mutations

Ann Hum Genet. 1999 Jan;63(Pt 1):1-8. doi: 10.1046/j.1469-1809.1999.6310001.x.

Abstract

The DYT1 gene on human chromosome 9q34 appears to be responsible for most cases of early onset primary torsion dystonia (PTD) both in Ashkenazi Jewish (AJ) and in non-Jewish patients. Previous haplotype analysis in a 2 cM region surrounding the DYT1 gene showed that a single founder mutation (DYT1AJ) was responsible for most cases of early onset PTD in the North American AJ population and refined the most likely location of the gene to a 150 kb interval between the marker loci D9S2161 and D9S63. Recently, the majority of cases of early onset PTD in both AJ and non-Jewish patients were found to carry a unique 3-bp (GAG) deletion in the coding region of the DYT1 gene. This deletion appears to have arisen more than once, suggesting independent mutational events. In this study, we analysed the haplotypes surrounding DYT1 in 9 AJ and 15 non-Jewish British patients carrying the GAG deletion in the DYT1 gene. We found that all AJ British patients carried the same haplotype as the North American Jews, sustaining the theory that the current British AJ community descends from the same small group of individuals as the North American Jewry. Furthermore, in the non-Jewish British patients, only a limited number of distinct founder mutations was observed. This supports the hypothesis that the GAG deletion in the DYT1 gene is not a very frequent mutation, and that it has arisen only a limited number of times throughout the centuries.

MeSH terms

  • Alleles
  • Carrier Proteins / genetics*
  • Chromosomes, Human, Pair 9 / genetics
  • Dystonia Musculorum Deformans / genetics*
  • Female
  • Founder Effect*
  • Genotype
  • Haplotypes
  • Humans
  • Jews / genetics
  • Linkage Disequilibrium
  • Male
  • Microsatellite Repeats
  • Molecular Chaperones*
  • Phenotype
  • Sequence Deletion*
  • United Kingdom

Substances

  • Carrier Proteins
  • Molecular Chaperones
  • TOR1A protein, human